Published in Mol Med on July 21, 2011
A novel immune competent murine hypertrophic scar contracture model: a tool to elucidate disease mechanism and develop new therapies. Wound Repair Regen (2015) 0.78
Admixture mapping identifies a locus at 15q21.2-22.3 associated with keloid formation in African Americans. Hum Genet (2014) 0.77
Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction. J Mol Med (Berl) (2014) 0.76
Pre-vascularization Enhances Therapeutic Effects of Human Mesenchymal Stem Cell Sheets in Full Thickness Skin Wound Repair. Theranostics (2017) 0.75
Cell migration: integrating signals from front to back. Science (2003) 29.13
Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol (2009) 7.77
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol (2007) 4.26
Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow. Biophys J (2006) 3.83
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev (2000) 3.40
Nonmuscle myosin II moves in new directions. J Cell Sci (2008) 3.39
Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press (2003) 1.79
The molecular basis of keloid and hypertrophic scar formation. Mol Med Today (1998) 1.77
Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res (1999) 1.77
Current progress in keloid research and treatment. J Am Coll Surg (2008) 1.52
Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med (Berl) (1997) 1.41
Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol (2004) 1.38
Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg (2005) 1.33
Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation (1988) 1.26
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. Oncogene (2006) 1.14
Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol (2005) 1.13
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum (2004) 1.07
Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism. Mol Cell Endocrinol (2008) 1.05
Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol (1994) 1.04
Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J (2006) 1.03
Human skin: source of and target organ for angiotensin II. Exp Dermatol (2004) 1.02
Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting. Trends Endocrinol Metab (2000) 0.99
Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin. J Am Acad Dermatol (2006) 0.97
Keloids and hypertrophic scars. Clin Dermatol (1994) 0.96
Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension (1997) 0.96
Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest (1994) 0.95
Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol (2005) 0.94
Fibrous tissue and angiotensin II. J Mol Cell Cardiol (1997) 0.91
Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol (1999) 0.91
Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives. J Med Chem (1994) 0.91
Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7). Plast Reconstr Surg (2003) 0.90
Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. Eur J Neurosci (2010) 0.89
Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen (2001) 0.88
Further evidence for the involvement of MYH9 in the etiology of non-syndromic cleft lip with or without cleft palate. Eur J Oral Sci (2009) 0.83
Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy. Drugs (2005) 0.81
Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension. J Hypertens (1999) 0.79
RAC activity in keloid disease: comparative analysis of fibroblasts from margin of keloid to its surrounding normal skin. Eplasty (2008) 0.78
[Contribution of angiotensin II type I and type II receptors(AT-1 and AT-2) to collagen synthesis by skin fibroblasts]. Nihon Rinsho (2002) 0.77
Local angiotensin II and myocardial fibrosis. Adv Exp Med Biol (1997) 0.77
[Mucocutaneous bullous pemphigoid induced by valsartan. A clinical case]. Minerva Stomatol (2003) 0.76
An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. Hum Pathol (2012) 2.02
Changes in dermal histomorphology following surgical weight loss versus diet-induced weight loss in the morbidly obese patient. Ann Plast Surg (2012) 1.98
Pump-probe imaging differentiates melanoma from melanocytic nevi. Sci Transl Med (2011) 1.86
Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol (2005) 1.79
A review of scar scales and scar measuring devices. Eplasty (2010) 1.50
Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol (2003) 1.50
The modified Patient and Observer Scar Assessment Scale: a novel approach to defining pathologic and nonpathologic scarring. Plast Reconstr Surg (2011) 1.49
A model of sequential heart and composite tissue allotransplant in rats. Plast Reconstr Surg (2010) 1.42
Routine versus selective abdominal computed tomography scan in the evaluation of right lower quadrant pain: a randomized controlled trial. Acad Emerg Med (2006) 1.18
Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res (2008) 1.11
CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol (2006) 1.09
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. J Am Acad Dermatol (2013) 1.09
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Mol Cancer Ther (2010) 1.08
The integrin-linked kinase regulates cell morphology and motility in a rho-associated kinase-dependent manner. J Biol Chem (2004) 1.08
Paget disease of the vulva: a study of 56 cases. Eur J Obstet Gynecol Reprod Biol (2009) 1.06
Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol (2012) 1.05
UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol (2003) 1.05
Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One (2012) 1.01
Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol (2006) 0.99
In vivo analysis of burns in a mouse model using spectroscopic optical coherence tomography. Opt Lett (2014) 0.99
Nonlinear microscopy of eumelanin and pheomelanin with subcellular resolution. J Invest Dermatol (2013) 0.97
Severe erythroderma as a complication of continuous epoprostenol therapy. Chest (2002) 0.93
Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation. J Immunol (2010) 0.92
Alopecia in IL-10-deficient mouse pups is c-kit-dependent and can be triggered by iron deficiency. Exp Dermatol (2010) 0.91
Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol (2011) 0.90
Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg (2009) 0.89
Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis (2005) 0.88
Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling. Lab Invest (2010) 0.88
Keratosis follicularis spinulosa decalvans in a family. J Am Acad Dermatol (2008) 0.87
Self-healing juvenile cutaneous mucinosis: cases highlighting subcutaneous/fascial involvement. J Am Acad Dermatol (2006) 0.86
Acquired vulvar lymphangioma circumscriptum: a comparison of 12 cases with Crohn's associated lesions or radiation therapy induced tumors. J Cutan Pathol (2010) 0.86
Basal cell-signet-ring squamous cell carcinoma of the eyelid. Arch Pathol Lab Med (2006) 0.85
Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol (2005) 0.85
CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. Cancer Prev Res (Phila) (2011) 0.83
Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. J Neuroimmunol (2010) 0.83
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma. Ann Surg (2012) 0.83
Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis. Arch Dermatol (2011) 0.83
Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase. Plast Reconstr Surg (2011) 0.82
Factors associated with transfer of hand injuries to a level 1 trauma center: a descriptive analysis of 1147 cases. Plast Reconstr Surg (2014) 0.82
Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents. Mol Cancer Ther (2007) 0.82
Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas. Hum Pathol (2006) 0.82
The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity. J Surg Res (2011) 0.82
Sterically demanding multidentate ligand tris[(2-(6-methylpyridyl))methyl]amine slows exchange and enhances solution state ligand proton NMR coupling to (199)Hg(II). Inorg Chem (2002) 0.81
Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. Melanoma Res (2011) 0.81
Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb. Arch Dermatol (2010) 0.80
Kaposi sarcoma presenting as yellow-green penile plaques in a black man with HIV. Cutis (2011) 0.80
Functional optical coherence tomography: principles and progress. Phys Med Biol (2015) 0.79
Vulvar adnexal lesions: a 32-year, single-institution review from Massachusetts General Hospital. Arch Pathol Lab Med (2013) 0.79
Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II. J Hand Surg Am (2010) 0.78
A novel immune competent murine hypertrophic scar contracture model: a tool to elucidate disease mechanism and develop new therapies. Wound Repair Regen (2015) 0.78
Complex abdominal wall hernias: a new classification system and approach to management based on review of 133 consecutive patients. Ann Plast Surg (2011) 0.78
Acute carpal tunnel syndrome secondary to iatrogenic hemorrhage. A case report. Hand (N Y) (2010) 0.77
Spatially inhomogeneous enhancement of fluorescence by a monolayer of silver nanoparticles. Langmuir (2006) 0.77
Erratum to: angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction. J Mol Med (Berl) (2015) 0.77
The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction. Plast Reconstr Surg (2014) 0.76
Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction. J Mol Med (Berl) (2014) 0.76
Hardware Removal in Craniomaxillofacial Trauma: A Systematic Review of the Literature and Management Algorithm. Ann Plast Surg (2015) 0.75
Calcium-dependent signaling in Dupuytren's disease. Hand (N Y) (2010) 0.75
Immunohistochemistry in the diagnosis of cutaneous neoplasms. Future Oncol (2010) 0.75
A systematic review of the psychometric properties of self-reported scales assessing burn contractures reveals the need for a new tool to measure contracture outcomes. Wound Repair Regen (2013) 0.75
Alveolar soft-part sarcoma of the tongue in a 17-month-old. Ear Nose Throat J (2009) 0.75
Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Arch Dermatol (2012) 0.75
GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms. Am J Dermatopathol (2017) 0.75
Abstract 166: electrospun synthetic scaffolds: a biomimetic approach to prevent hypertrophic scar contraction. Plast Reconstr Surg (2014) 0.75
Practical radiation oncology for extremity sarcomas. Surg Oncol Clin N Am (2013) 0.75
What is your diagnosis? Lupus profundus. Am J Dermatopathol (2002) 0.75
Abstract 34: a novel immune competent murine hypertrophic scar contracture model: a tool to elucidate disease mechanism and develop new therapies. Plast Reconstr Surg (2014) 0.75
Asian-American rhinoplasty. Aesthet Surg J (2009) 0.75
Dual-axis optical coherence tomography for deep tissue imaging. Opt Lett (2017) 0.75
Type V aplasia cutis congenita: case report, review of the literature, and proposed treatment algorithm. Pediatr Dermatol (2012) 0.75
Amicrobial Pustulosis of the Folds and Autoimmunity. J Low Genit Tract Dis (2016) 0.75
Differentiated Vulvar Intraepithelial Neoplasia: What Criteria Do We Use in Practice? J Low Genit Tract Dis (2016) 0.75
Alpha-lipoic acid is ineffective as a topical antioxidant for photoprotection of skin. J Invest Dermatol (2004) 0.75
Polycationic Nanofibers for Nucleic Acid Scavenging. Biomacromolecules (2016) 0.75
Sharply demarcated, erythematous plaques on an amputation stump--quiz case. Arch Dermatol (2009) 0.75
Cutaneous acquired toxoplasmosis in a child: a case report and review of the literature. Am J Dermatopathol (2015) 0.75
Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications. J Am Acad Dermatol (2011) 0.75
Diffuse hypopigmented macules. Arch Dermatol (2006) 0.75
The Effect of Microporous Polysaccharide Hemospheres on Wound Healing and Scarring in Wild-Type and db/db Mice. Adv Skin Wound Care (2017) 0.75
Ubiquinone, idebenone, and kinetin provide ineffective photoprotection to skin when compared to a topical antioxidant combination of vitamins C and E with ferulic acid. J Invest Dermatol (2006) 0.75